How do you eat out or at a wedding on Ozempic or Mounjaro?
Neither the US labels for Ozempic (semaglutide) and Mounjaro (tirzepatide) nor India's ESI 2025 guideline set separate rules for eating out. The ESI's general tips are small, frequent meals and avoiding high-fat meals and alcohol. With insulin or a sulfonylurea, a late or skipped meal can raise the risk of low blood sugar (a hypo).
- GLP‑1 medicines such as Ozempic and Mounjaro are prescription-only in India, not sold over the counter.11
- A government statement on 1 Apr 2026 said only endocrinologists, internal-medicine specialists and cardiologists can prescribe them.11 CDSCO expert-committee minutes attach a similar condition to some approvals (endocrinologist or internal-medicine specialist), but we found no rule covering every brand.12,13
- The risks are in Guide 5: Side effects and risks.
- This page is about eating while already on a GLP‑1. Losing a few kilos before a wedding is a different question, covered in our path on that.
Do the labels or Indian guidelines say anything about eating out?
We found no mention of restaurants, parties or weddings in the US Ozempic and Mounjaro labels or in India's ESI 2025 guideline.1,2,3
Both labels say the weekly dose can be taken any time, with or without meals.1,2 The ESI's food advice, aimed at side effects, lists small, frequent meals and avoiding high-carbohydrate, high-fat and high-fibre meals, fizzy drinks and alcohol.3
Expert panels in the US, India and Spain give similar tips.4,5,6 The US panel says its advice rests on "limited available evidence and expert opinion".4 Our posts on foods that make side effects worse and Indian meals on a GLP‑1 go through those lists.
What does guidance say about a big meal at a wedding or restaurant?
Expert panels describe smaller portions, eating slowly and stopping when comfortably full, and both labels say these medicines slow how fast the stomach empties.1,2,5,6
A 2025 US advisory says vomiting is more likely with large meals, and foods high in protein or fat slow emptying further.4 An Indian expert consensus adds avoiding large evening meals to reduce nausea.5 Both points fit a large wedding dinner.
The US advisory also lists long gaps without food, becoming "overly hungry", as something to limit. It encourages "portion-controlled treats" and "flexibility with food choices".4 The NHS says alcohol is best avoided on semaglutide and tirzepatide, as it can increase nausea and vomiting.8
What does a diabetes charity suggest for buffets and Indian menus?
Diabetes UK's eating-out page mentions weddings and buffets, though it was written for people with diabetes, not for GLP‑1 medicines.7
At a buffet, it suggests looking at the whole table first, then making one trip before dessert.7 For Indian food, it points to tandoori and tikka dishes, which are baked and lower in fat. It prefers boiled or steamed rice to pilau or fried rice, and wholemeal chapatti or roti to naan.7 That tip is for diabetes; the ESI's high-fibre caution is about stomach side effects, so they pull different ways.3,7
Its healthier starters are soups, vegetable sticks with dips and salads, or chicken tikka and grilled fish, rather than samosas and pakoras. It says fried snacks such as sev and gathia can be high in fat and salt.7 For dessert, it calls a sweet treat now and again fine, but says it is easy to eat too much. It suggests sharing rich foods such as kulfi.7 It notes meals out can shift meal times and stretch over a longer period.7
Build a list of questions to ask. Free, no sign-up.
Why does meal timing matter with insulin or a sulfonylurea?
Both labels say taking Ozempic or Mounjaro with insulin or a sulfonylurea, such as glimepiride, raises the risk of hypos, including severe ones.1,2
The glimepiride label adds that hypos are more likely when you eat too little or drink alcohol.10 The NHS lists not skipping or delaying meals, and not drinking alcohol without eating, among ways to avoid them.9 Diabetes UK says people on twice-daily insulin may need a carbohydrate snack if lunch out is later than usual.7
Signs listed on the Ozempic label include shakiness, sweating, hunger, confusion and a fast heartbeat.1 Our post on low blood sugar on GLP‑1 medicines covers treatment; the type 2 diabetes path links the rest.
- Nausea is common. In US diabetes trials, 16% to 20% on Ozempic vs 6% on a dummy injection, and 12% to 18% on Mounjaro vs 4%.1,2
- Pancreatitis. Severe stomach pain that won't go away, sometimes reaching the back.2
- Gallbladder problems, including gallstones.1,2
- Dehydration from vomiting or diarrhoea can cause kidney problems.1
- Hypos with insulin or a sulfonylurea.1,2
- Thyroid warning. Thyroid C-cell tumours in rodents. Ruled out by the US labels for anyone with a personal or family history of MTC or MEN 2; tell your doctor if this applies.1,2
- Pregnancy. Animal studies suggest possible harm to the baby. Ozempic's label says to stop at least 2 months before a planned pregnancy.1,2
Read the full picture
Related questions
Sources
- Novo Nordisk. Ozempic (semaglutide) US prescribing information and Medication Guide, revised 05/2026. US label, not the Indian one: we found no public Indian label. Table 1 and Medication Guide. novo-pi.com
- Eli Lilly. Mounjaro (tirzepatide) US prescribing information, revised 08/2026. US label, not the Indian one. Table 1. pi.lilly.com
- Madhu SV, Kapoor N, Das S, Raizada N, Kalra S. ESI clinical practice guidelines for the evaluation and management of obesity in India: an update (2025). Indian J Endocrinol Metab 2025. Table 6. doi:10.4103/ijem.ijem_680_25 · PMID 40917319
- Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory (ACLM, ASN, OMA, TOS). Obesity 2025;33:1475-1503. Table 6. Several authors declare Novo Nordisk or Eli Lilly ties. PMC12304835 · PMID 40445127
- Joshi SR, Misra A, Mithal A et al. Nutritional considerations for glucagon-like peptide-based therapies: an Asian Indian consensus recommendation. Obes Pillars 2026;19:100296. Table 9 and statement 18. Funded by Abbott Nutrition International, India. doi:10.1016/j.obpill.2026.100296 · PMID 42529748
- Gorgojo-Martínez JJ et al. Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus. J Clin Med 2023;12(1):145. Table 2. Funded by Novo Nordisk. PMC9821052 · PMID 36614945
- Diabetes UK. Eating out with diabetes (page modified 24 Mar 2026). Written for people with diabetes, not about GLP-1 medicines. diabetes.org.uk
- NHS. Semaglutide; Tirzepatide (both pages last reviewed 15 May 2026). nhs.uk/semaglutide · nhs.uk/tirzepatide
- NHS. Low blood sugar (hypoglycaemia) (page last reviewed 3 Aug 2023). UK page; the UK emergency number is 999, India's is 112. nhs.uk
- Glimepiride tablets US prescribing information (DailyMed). US label. dailymed.nlm.nih.gov
- Press Information Bureau (Research Unit), Government of India. GLP-1 drugs: use, risks, and regulation. 1 Apr 2026. PDF
- CDSCO. Recommendations of the Subject Expert Committee (Endocrinology and Metabolism), meeting of 20–21 Apr 2023, item 1 (tirzepatide). PDF · archived copy
- CDSCO. Recommendations of the Subject Expert Committee (Endocrinology and Metabolism), meeting of 13–14 Feb 2024, items 3–4 (semaglutide). PDF · archived copy
Last checked 5 Oct 2026 · Next review due 5 Oct 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above. We searched the labels, the ESI guideline and the expert papers for eating out, restaurants and weddings, and found none; we found no source on Indian weddings and GLP‑1 medicines. It's general information, not medical advice. Talk to a qualified doctor before starting, stopping or changing any medicine. How we write